We searched the medical databases PubMed, MEDLINE, EMBASE, and The Cochrane Library (from January, 1985, to October, 2004) using the term “melanoma”, with relevant subheadings. We also searched the reference lists in articles identified by this strategy and selected additional articles that we judged to be relevant. Several review articles and book chapters were included as references because they provided comprehensive overviews of topics that are beyond the scope of this Seminar.
SeminarCutaneous melanoma
Introduction
Melanoma has become a major public health problem in many countries. Since the mid 1960s, melanoma incidence has risen by 3–8% per year in most people of European background, with the greatest increases in elderly men.1 Despite this increase, and an overall rise in mortality due to melanoma, the survival rate has improved substantially.2 Roughly 60% of those diagnosed with melanoma in the 1960s died of the disease, compared with just 11% more recently, an improvement attributed mainly to early detection.2
Section snippets
Epidemiology
Table 1 shows international trends in melanoma incidence and mortality rates. 5-year survival has steadily improved over recent decades, and is now greater than 85%,8 but melanoma causes disproportionate mortality in those of young and middle age, such that an average of 18·6 years of potential life are lost for each melanoma death in the USA, one of the highest rates for adult-onset cancers.4, 9 The evidence of a causative link with sunlight exposure is compelling, with severe episodic sunburn
Pathogenesis
Ultraviolet solar radiation promotes malignant change in the skin by having direct mutagenic effects on DNA, by stimulating the cellular constituents of the skin to produce growth factors, by reducing cutaneous immune defences, and by promoting reactive oxygen species of melanin that cause DNA damage and suppress apoptosis.25 Melanoma develops as a result of accumulated abnormalities in genetic pathways within the melanocyte. These abnormalities promote cell proliferation and prevent normal
Sun-protective behaviour
Physical protection from exposure to sunlight is generally accepted as the most important element of melanoma risk reduction.48 When shade is not available, sun-protective clothing and hats should be worn, peak hours of sun intensity should be avoided, and sunburn should be prevented. These measures may be especially important in children and adolescents.49, 50, 51 Large changes in attitude and behaviour towards sun protection in Australia have been attributed to the success of widespread
Recognition of early melanoma
The most important factor for successful management of melanoma is early diagnosis, allowing treatment to be undertaken at a stage when cure is readily achievable. Most melanomas can be identified clinically by careful examination with good lighting and magnification. Several characteristics are usually present and recognisable, including asymmetry, border irregularity, colour variegation, and a diameter greater than 6 mm. These features have been used as the so-called ABCD system of diagnosis.
Lymphatic mapping and sentinel node biopsy
Until the early 1990s, controversy had existed for decades about the value of elective lymph-node dissection (ELND) for patients who presented with a primary melanoma but who had no clinical evidence of regional node metastasis. Several large retrospective studies appeared to show a survival benefit,116 but randomised trials did not.89, 117, 118 The short-term and long-term morbidity of ELND was substantial, and only 20% of patients had nodal metastases. Then, in 1992, sentinel node (SN) biopsy
Metastatic melanoma
Little progress has been made in medical treatment of metastatic melanoma because of the absence of effective systemic therapies. Most patients with metastatic disease confined to skin, subcutis, and lymph nodes will survive for 12 months, whereas those with visceral involvement or an elevated concentration of LDH in serum have a median survival of only 4–6 months.91
Conclusions
Steady improvements in early detection rates and the surgical management of early disease have resulted in cure for most patients who present with primary melanoma. Substantial advances have also been made in understanding of the molecular pathogenesis of melanoma and the interaction between sunlight and host risk factors that underpin it. Advanced melanoma evolves with an extensive repertoire of molecular defences against immunological and cytotoxic attack—a challenge to the development of
Search Strategy and Selection Criteria
Conflict of
References (189)
- et al.
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient?
Eur J Cancer
(2003) - et al.
The epidemiology of UV induced skin cancer
J Photochem Photobiol B
(2001) - et al.
Genetic epidemiology of familial melanoma
Dermatol Clin
(1995) - et al.
How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?
J Am Acad Dermatol
(1993) - et al.
Basal cell carcinoma and risk of subsequent malignancies: a cancer registry-based study in southwest England
J Am Acad Dermatol
(2000) - et al.
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens
J Am Acad Dermatol
(1999) - et al.
Genetic testing for melanoma
Lancet Oncol
(2002) The tumor suppressor protein p16INK4a
Exp Cell Res
(1997)- et al.
Localization of a novel melanoma susceptibility locus to 1p22
Am J Hum Genet
(2003) - et al.
Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic review
Am J Prev Med
(2004)
Personal risk-factor chart for cutaneous melanoma
Lancet
American College of Preventive Medicine practice policy statement: skin protection from ultraviolet light exposure
Am J Prev Med
Amelanotic melanoma: cases studied by Fontana stain, S-100 immunostain, and ultrastructural examination
Mayo Clin Proc
Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection
J Am Acad Dermatol
Diagnostic accuracy of dermoscopy
Lancet Oncol
Dermoscopy and its role in diagnosing melanocytic lesions: a guide for pathologists
Pathology
Frontiers in melanocytic pathology
Pathology
Cooperation between surgical oncologists and pathologists: a key element of multidisciplinary care for patients with cancer
Pathology
The use and application of special techniques in assessing melanocytic tumours
Pathology
Molecular genetics of melanocytic neoplasia: practical applications for diagnosis
Pathology
Adjuvant therapy of cutaneous melanoma: the interferon debate
Ann Oncol
Epidemiology of cutaneous melanoma and current trends
The melanoma epidemic: res ipsa loquitur
Oncologist
Australasian Association of Cancer Registries (AACR) 2003
Cancer in Australia
SEER cancer statistics review, 1975–2001
Cancer statistics, 2004
CA Cancer J Clin
Statisitcs: cancer stats reports
Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994
BMJ
Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma
Br J Dermatol
Melanoma etiology: where are we?
Oncogene
Geographical variation in the penetrance of CDKN2A mutations for melanoma
J Natl Cancer Inst
Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE)
Int J Cancer
Melanoma epidemiology
Curr Opin Oncol
Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia
Int J Cancer
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma
JAMA
Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935–82
Natl Cancer Inst Monogr
Risk of cancer in people with AIDS
AIDS
Use of host factors to identify people at high risk for cutaneous malignant melanoma
CMAJ
Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE)
Int J Cancer
Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk
Clin Cancer Res
Cellular and molecular biology of human melanoma
Cancer Biol Ther
Cancer genes and the pathways they control
Nat Med
Apoptosis and melanoma chemoresistance
Oncogene
Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines
Oncogene
Mutations of the BRAF gene in human cancer
Nature
BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma
Cancer Res
Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas
Clin Cancer Res
High frequency of BRAF mutations in nevi
Nat Genet
BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin
Am J Dermatopathol
The pathogenesis of melanoma induced by ultraviolet radiation
N Engl J Med
Cited by (575)
Machine learning modeling and prognostic value analysis of invasion-related genes in cutaneous melanoma
2023, Computers in Biology and MedicineIonic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma
2022, Journal of Controlled Release